Leverens tilstand bedredes hos 55% af de patienter, der blev behandlet med Baraclude, mod 28% af dem, der blev behandlet med lamivudin.
55% of patients treated with Baraclude had improvements in the condition of their liver, against 28% of those treated with lamivudine.